In recent years, Mozambique has made significant progress in organising the National Health System and in the availability of medicines for priority areas such as HIV, tuberculosis (TB), malaria, and sexual and reproductive health. At the same time, the Access to Medicines Scorecard (A2M) reveals persistent structural weaknesses in transparency, governance, financing and social participation. These weaknesses increase the risk of disruptions in a context of high donor dependence and limit the state’s ability to sustainably guarantee the right to health.

This Policy Brief proposes a roadmap focused on five priority areas: active transparency and data governance; budget predictability and integration between planning, finance and logistics; strategic use of TRIPS flexibilities and intellectual property in favour of public health; social participation and equity as structural elements of medicines policy; and strengthening rational use, pharmacovigilance and preparedness for innovation. None of these areas is entirely new, but addressing them in an integrated manner, with clear responsibilities and monitorable targets, can produce a qualitative leap forward.